lnterleukin-6 (IL-6) in Synovial Fluid and Serum of Patients with Rheumatic Diseases
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 17 (6) , 469-474
- https://doi.org/10.3109/03009748809098809
Abstract
Swaak AJ, van Rooyen A, Nieuwenhuis E, Aarden LA. Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatoid disease. Scand J Rheumatology 1988; 17: 469-474. Interleukin-6 (IL-6) is a monokine with a number of biological activities, which are intimately related to inflammatory responses. We have measured IL-6 levels in synovial fluid (SF) and serum (Se) of patients with rheumatic diseases. SF-IL-6 levels were a thousand-fold higher than corresponding Se levels and a positive correlation was found between SF and Se levels suggesting that Se-IL-6 is derived from IL-6 produced in the joint. Se levels of IL-6 were also positively correlated to C-reactive protein (CRP) levels, supporting the in vitro experiments showing that IL-6 stimulates hepatocytes to produce CRP. Finally we observed a positive corelation between SF-IL-6 levels and the local activity score. A. J. G. Swaak, Department of Rheumatology, The Dr Daniel den Hoed Clinic, Groene Hill-edijk 301, NL-3075 EA Rotterdam, The Netherlands.Keywords
This publication has 14 references indexed in Scilit:
- Functional discrimination between interleukin 6 and interleukin 1European Journal of Immunology, 1988
- Interleukin 6 is involved in interleukin 1‐induced activitiesEuropean Journal of Immunology, 1988
- Induction of rat acute‐phase proteins by interleukin 6 in vivoEuropean Journal of Immunology, 1988
- Hepatocyte-stimulating factor, beta 2 interferon, and interleukin-1 enhance expression of the rat alpha 1-acid glycoprotein gene via a distal upstream regulatory region.Molecular and Cellular Biology, 1988
- SERUM LEVELS OF INTERLEUKIN-6 AND ACUTE PHASE RESPONSESThe Lancet, 1987
- Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.Proceedings of the National Academy of Sciences, 1987
- Synthesis of hemopexin and cysteine protease inhibitor is coordinately regulated by HSF-II and interferon-β2 in rat hepatoma cellsBiochemical and Biophysical Research Communications, 1987
- Production of hybridoma growth factor by human monocytesEuropean Journal of Immunology, 1987
- Structural analysis of the sequence coding for an inducible 26‐kDa protein in human fibroblastsEuropean Journal of Biochemistry, 1986
- Induction of a 26-kDa-protein mRNA in human cells treated with an interleukin-1-related, leukocyte-derived factorEuropean Journal of Biochemistry, 1985